Development of a Scalable Process for the Synthesis of DNDI-VL-2098: A Potential Preclinical Drug Candidate for the Treatment of Visceral Leishmaniasis.

Satam, Vijay S; Pedada, Srinivasa Rao; Kamaraj, Pasumpon; Antao, Nakita; Singh, Apoorva; Hindupur, Rama Mohan; Pati, Hari N; Thompson, Andrew M; Launay, Delphine; Martin, Denis

Satam, Vijay S; Pedada, Srinivasa Rao; Kamaraj, Pasumpon; Antao, Nakita; Singh, Apoorva; Hindupur, Rama Mohan; Pati, Hari N; Thompson, Andrew M; Launay, Delphine; Martin, Denis.

Satam VS; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Pedada SR; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Kamaraj P; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Antao N; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Singh A; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Hindupur RM; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Pati HN; Process Chemistry Division, Advinus Therapeutics Ltd., 21 & 22, Phase II, Peenya Industrial Area, Bangalore 560058, Karnataka, India.
Thompson AM; Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Launay D; Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Louis Dunant, 1202 Geneva, Switzerland.
Martin D; Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Louis Dunant, 1202 Geneva, Switzerland.